Investment Committee Summary
| Rating | SELL |
| Internal 5-tier | SELL |
| Classification · conviction | income compounder · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | ~$17 (≈ -28% vs spot) — precision reflects LOW valuation confidence |
| 12-mo scenario PWEV | ~$18 (≈ -24% vs spot) |
| Next catalyst | 2026-09-30 — Brazil (Mosaic Fertilizantes) volume/margin and grain-affordability update |
| Primary thesis-break | Potash + phosphate realised selling price (segment MDA disclosure) below the level implied between the Base and Downturn paths (mid-single-digit annual price decline) (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: SELL
Internal 5-tier: SELL · income compounder · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $24.00 |
| Triangulated Fair Value | $17.25 (-28% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $18.32 (-24% vs spot · 12m PWEV) |
| Forward P/E | 24.5x |
| Market Cap | $7B |
| 52-Week Range | $19.80–$36.94 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across two weighted anchors — a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 37.3/100 (3rd pct) | -24% 1yr expected | Hold | Collar | 36d — Brazil (Mosaic Fertilizantes) volume/margin and grain-affordability update |
Research rating: SELL · Tactical / decision-rule stance: Hold — the stance is the machine decision-rules layer (hysteresis, kill-switches, freshness); the rating is the valuation verdict. They may diverge and are reconciled in the Decision Rules section below.
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: SELL
Defensive: rating SELL; triangulated fair value $17.25 (-28% vs spot) — the risk/reward is skewed to the downside on Gross Margin. The debate is Gross Margin — a fundamental call.
Investment Thesis
At $24.00 on 25 August 2026 the market pays a low multiple of revenue and 24x forward earnings, pricing Mosaic as a deep cyclical stuck near the low end of a nutrient cycle rather than as a structurally impaired one. Our engine disagrees about where in the cycle we actually sit. The single Fertilizers segment earns a group operating margin of only 3.1% on trailing numbers, and the probability tree leans on the structural and downturn paths, which together carry more weight than the base case. Recomputed scenario earnings span a very wide band, so most of the payoff distribution clusters low: a twelve-month target of $17.64 and a triangulated value of $17.25 leave the shares trading rich to our anchors (-28% versus spot), and the rating is SELL. The cash-flow anchor is lower still, penalising a rising capital-spending glidepath while depreciation lags and incremental return on invested capital reads close to nothing — though that anchor diverges far enough from the simulated median that it should be read as a direction, not a number. The single most damaging risk to this call is a genuine supply shock: constrained potash or phosphate output would lift realised prices and margin quickly, and a margin base this thin is violently geared to any upside surprise in nutrient pricing.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($24.00) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The bear leg the engine leans on is a nutrient oversupply reset, and it is a real mechanism rather than a hedge. New potash and phosphate capacity from lower-cost basins, weaker farmer affordability as grain prices ease, and a demand reset together push realised nutrient prices below cash-cost support for the marginal tonne. An operating margin already as thin as 3.1% compresses toward nothing on that path, while the multiple de-rates from 24x to a trough level, so earnings and rating fall in the same direction. With capital spending still climbing against a lower depreciation charge, free cash flow thins precisely when it is most needed to defend the distribution, and net debt of ~$0.9B grows heavier against a shrinking cash-flow base. The result is a structural target below the 52-week low. For a commodity producer with no pricing power, that is the ordinary shape of a downcycle, not a catastrophe scenario.
Key Debate
Gross Margin explains 85% of Monte Carlo outcome variance — the single variable that decides which side is right.
What the Market Is Pricing In
At the current price, the market pays 60.1× consensus forward EPS, vs the house DCF terminal 15.0×, and a peer median 15.8×. The house DCF sits 70% below spot, so the market is pricing in more than the house case — roughly 3.8pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 12.2 | 12.7 | High |
| EPS | 0.4 | 1.0 | Medium |
| Target price | 27.6 | 17.6 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Nutrient Oversupply / Demand Reset' downside ($5.10) to a 'Spike — Supply Shock (gas / geopolitics)' bull case ($41.30); the probability-weighted blend (PWEV $18.32) is -24% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Nutrient Oversupply / Demand Reset | 24% | $5.10 | -79% |
| Downturn — Price Trough | 18% | $10.60 | -56% |
| Base — Mid-Cycle Nutrient Prices | 32% | $19.20 | -20% |
| Upcycle — Tight Nutrient Balance | 18% | $31.90 | +33% |
| Spike — Supply Shock (gas / geopolitics) | 8% | $41.30 | +72% |
| Probability-Weighted (PWEV) | — | $18.32 | -24% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.2% of revenue; free cash flow net of SBC is $-0.57B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Nutrient Oversupply / Demand Reset (24%, $5.10). Structural impairment — nutrient glut / demand reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Downturn — Price Trough (18%, $10.60). Cyclical downturn — nitrogen/potash/phosphate prices + natural-gas cost + crop demand weakens for 1–2 years before normalising.
- Base — Mid-Cycle Nutrient Prices (32%, $19.20). Mid-cycle — normalised nitrogen/potash/phosphate prices + natural-gas cost + crop demand; disciplined capital allocation; steady returns.
- Upcycle — Tight Nutrient Balance (18%, $31.90). Upside — supply shock / tight balance lifts earnings above mid-cycle; the multiple expands modestly.
- Spike — Supply Shock (gas / geopolitics) (8%, $41.30). Upside tail — sustained tight conditions or a structural re-rate on supply shock / tight balance.
Valuation Triangulation
Two weighted anchors — a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat two numbers as two independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $15.46 | -36% | 37% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $80.65 | +236% | 0% — cross-check only |
| Scenario PWEV | multiple | $18.32 | -24% | 62% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $7.30 | -70% | 0% — excluded |
| Triangulated (weighted) | — | $17.25 | -28% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name DCF, sum-of-parts, peer P/E re-rate are not computed, so 60% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $15.46 and 38% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (85% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.5%, 15.0x terminal FCF multiple → $7.30. Excluded from the weighted blend as an outlier — retained as an independent cross-check on the multiple-driven anchors.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $80.65; the peer-median forward P/E is 15.8x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 400% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 10.5x | 12.8x | 15.0x | 17.2x | 19.5x |
|---|---|---|---|---|---|
| 7.5% | $5.72 | $6.97 | $8.17 | $9.37 | $10.62 |
| 8.5% | $5.38 | $6.58 | $7.72 | $8.87 | $10.06 |
| 9.5% | $5.07 | $6.21 | $7.30 | $8.39 | $9.53 |
| 10.5% | $4.76 | $5.85 | $6.90 | $7.94 | $9.03 |
| 11.5% | $4.47 | $5.52 | $6.51 | $7.51 | $8.55 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-6.20 | $-0.30 | $5.59 | $11.49 | $17.38 |
| -1.5pp | $-6.17 | $0.12 | $6.42 | $12.72 | $19.02 |
| +0.0pp | $-6.15 | $0.58 | $7.30 | $14.02 | $20.74 |
| +1.5pp | $-6.12 | $1.05 | $8.23 | $15.40 | $22.57 |
| +3.0pp | $-6.09 | $1.56 | $9.21 | $16.85 | $24.50 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $-6.00 | $21.00 | $27.00 |
| Capex intensity ±15% | $-2.00 | $17.00 | $19.00 |
| Revenue CAGR ±3pp | $6.00 | $9.00 | $4.00 |
| Terminal × ±15% | $6.00 | $8.00 | $2.00 |
| WACC ±1pp | $7.00 | $8.00 | $1.00 |
Company lever — SoP/share vs Fertilizers (N / P / K) multiple (AI re-rating) (base 18.0x)
| Multiple | 12.6x | 15.3x | 18.0x | 20.7x | 23.4x |
|---|---|---|---|---|---|
| SoP/share | $13.00 | $16.00 | $20.00 | $23.00 | $26.00 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| CTVA | 22.8× | 5% | 24% | direct | 100% |
| CF | 5.9× | 2% | 34% | broad | 25% |
| AVY | 16.3× | 3% | 13% | segment | 50% |
| BALL | 15.4× | 3% | 9% | segment | 50% |
Quality-weighted forward P/E: 17.9× (simple median 15.8×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (Gordon) (excluded (>3× or <0.3× spot)). Anchor median 11.4. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $19.80–$36.94, centre $27.00 (+13% vs spot); spot sits at the 25th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $17.25 (-28% vs spot · triangulated FV) |
| Downside to bear case (Structural — Nutrient Oversupply / Demand Reset) | $5.10 (-79% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -39% |
| P(price > spot) — Monte Carlo | 38% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Spike — Supply Shock (gas / geopolitics)): $41.30.
Company Overview & Business Model
The Mosaic Company — BASIC MATERIALS · AGRICULTURAL INPUTS. The Mosaic Company is a Fortune 500 company based in Tampa, Florida which mines phosphate and potash, and operates through segments such as international distribution and Mosaic Fertilizantes.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Fertilizers (N / P / K) | 100% | +2% | 3% | nitrogen/potash/phosphate prices + natural-gas cost + crop demand |
Edge. Narrow moat — Mosaic's advantage is low-cost potash reserves (Saskatchewan) and phosphate integration plus scale, but it is a price-taker in a global nutrient commodity with no pricing control; the terminal multiple should stay cyclical-low (~8-10x mid-cycle EPS, ~0.6-0.8x EV/revenue), and only a durable tight-supply regime - not a spot spike - would justify anything higher.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Fertilizers (N / P / K) | $12.4B | 100% | 2% | 3% | $0.4B | 18.0x | 8% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | nitrogen/potash/phosphate prices + natural-gas cost + crop demand |
| net_debt_or_cash_b | -0.92 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.08 |
| div_yield | 0.0414 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | nutrient glut / demand reset |
| upside | supply shock / tight balance |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $5.0B — levered |
| Net debt / EBITDA | 2.91x |
| Interest coverage (EBIT / interest) | 6.6x |
| Current ratio | 1.32x |
| Lease obligations | $0.2B |
| Cash & ST investments | $0.3B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $-0.5B |
| Buybacks / dividends | $0.0B / $0.3B |
| Total shareholder yield | 3.8% |
| Payout as % of FCF | -52.3% |
| Reinvestment (capex / OCF) | 164.7% |
| SBC as % of FCF | -5.8% |
| Allocation stance | reinvesting |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | -4.3% |
| FCF conversion (FCF / net income) | -93.0% |
| FCF yield | -7.3% |
| Capex intensity (capex / revenue) | 11.0% |
| FCF − SBC (diagnostic) | $-0.6B |
| Capex split (maint / growth) | 65% / 35% — Capital-intensive miner (~8% of revenue capex); sustaining/mine-maintenance capital dominates, with a growth slug for potash brownfield expansion and Brazil logistics. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 144% — cash-backed.
Competitive Moat
Moat sources:
- Long-life low-cost potash reserves in Saskatchewan (favourable cost-curve position)
- Integrated phosphate mining and processing scale
- Logistics/distribution network in the Americas (Mosaic Fertilizantes in Brazil)
- NO pricing power - a price-taker in a globally traded nutrient commodity subject to oversupply
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.21 vs analyst floor +0.00 → delta +0.21 (n=26 mgmt / 12 Q&A; 12th pctile across the S&P book, z -1.3).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.21 | +0.00 | +0.21 |
| 2026Q1 | +0.29 | +0.00 | +0.29 |
| 2025Q4 | +0.33 | +0.08 | +0.25 |
| 2025Q3 | +0.37 | +0.11 | +0.27 |
News (last 365d, 1230 articles): avg ticker sentiment +0.06 (bullish 13% / bearish 11%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $27.56 (+15% vs spot · street) |
| House target | $17.64 (-36.0% vs street) |
| Sell-side coverage | 20 analysts (SB 4 / B 6 / H 9 / S 0 / SS 1; net score 0.3) |
| Consensus FY EPS | $0.40 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $12.2B; house above (+4.2%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-09-30 (~37d) — Brazil (Mosaic Fertilizantes) volume/margin and grain-affordability update (authored)
- 2026-10-15 (~52d) — New global potash capacity ramp (BHP Jansen and others) milestone (authored)
- 2027-01-15 (~144d) — Potash / phosphate contract settlements (India, China, Brazil) (authored)
Forecast Track Record
- EPS surprise: beat 38% of the last 8 quarters; average surprise -20.3%.
- Prior-forecast backtest (11 snapshots, 2026-06-26→2026-08-20): directional hit-rate 0%; mean predicted -21.5% vs realised +6.8%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-09-30 (in 36d) | Brazil (Mosaic Fertilizantes) volume/margin and grain-affordability update | authored | ● | 0.7 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-15 (in 51d) | New global potash capacity ramp (BHP Jansen and others) milestone | authored | ● | 0.7 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-15 (in 143d) | Potash / phosphate contract settlements (India, China, Brazil) | authored | ● | 0.7 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Fertilizer trade actions / tariffs and export restrictions (Russia, Belarus, China) | medium (~40%) | high - trade flows drive nutrient price; swings ~10-15% of FV either way | 12-24m |
| Phosphate mining/environmental permitting (Florida gypstacks, water) | medium (~35%) | medium - remediation and permit constraints ~4-6% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Nutrient Oversupply / Demand Reset | New low-cost potash/phosphate capacity floods the market as grain prices ease and farmer affordability weakens, resetting real nutrient prices lower | As a price-taker with no supply control, Mosaic's earnings are hostage to a structurally lower price deck |
| Downturn — Price Trough | Nutrient prices trough at cycle lows on soft demand and ample inventory | Operating leverage means trough prices can push margins to breakeven despite the low-cost reserves |
| Base — Mid-Cycle Nutrient Prices | Potash/phosphate settle at mid-cycle prices with balanced supply and steady application rates | Mid-cycle is a knife-edge - a modest supply addition or grain-price slip tips it toward the downturn |
| Upcycle — Tight Nutrient Balance | Tight supply-demand balance and firm grain prices lift nutrient prices above mid-cycle | Upcycle pricing is transient; it accelerates competitor capacity that later floods the market |
| Spike — Supply Shock (gas / geopolitics) | A natural-gas cost spike or geopolitical export disruption (Russia/Belarus) sharply tightens nutrient supply | Spikes are short-lived and demand-destroying; extrapolating them into terminal value is the classic cyclical trap |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 1 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-26.5 | YES |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-26.5 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.3 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
143.5 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
0.99 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
1.16 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Potash + phosphate realised selling price (segment MDA disclosure) below the level implied between the Base and Downturn paths (mid-single-digit annual price decline) (2 consecutive prints). Realised nutrient prices are the primary earnings driver; a sustained decline below the mid-cycle band shifts weight from Base toward the Downturn and Structural paths.
- Consolidated adjusted operating margin below 3.1% (the midpoint between the Base 3.4% and Downturn 2.8% path op-margins) (2 consecutive prints). Margin sitting under the Base/Downturn midpoint confirms cost pressure or price weakness is outrunning volume, validating the compressed-earnings leg of the bear scenarios.
- Annual capital expenditure above $1.50B (the top of the authored capex schedule) (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Net-debt / trailing EBITDA above 1.5x (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Global grain stocks-to-use ratio (USDA WASDE) above the 5-year average by more than one full percentage point (2 consecutive prints). Rising stocks-to-use signals slack crop demand and lower farmer affordability, the leading indicator for a nutrient demand reset that pushes realised prices toward the Structural path.
Fact / Inference / Speculation
- FACT: Spot $24.00; 52-week range $19.80–$36.94; engine rating SELL; house target $17.64 (-26%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $17.25 (-28% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
37.3/100 (confidence band 26.7–47.9), 3rd percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 37 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 34 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 24 | 15% | upside_pct |
| growth | 46 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 38 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 46 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 58 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 23 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 35.5 → 35.5 → 36.3 → 35.4 → 35.4 → 37.1 → 40.2 → 40.2.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Nutrient Oversupply / Demand Reset | 24% | $5.10 | -78.8% | -18.9pp |
| Downturn — Price Trough | 18% | $10.60 | -55.8% | -10.1pp |
| Base — Mid-Cycle Nutrient Prices | 32% | $19.20 | -20.0% | -6.4pp |
| Upcycle — Tight Nutrient Balance | 18% | $31.90 | +32.9% | +5.9pp |
| Spike — Supply Shock (gas / geopolitics) | 8% | $41.30 | +72.1% | +5.8pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | -23.7% |
| Expected return net of SBC dilution | -23.7% |
| Outcome dispersion (σ, from MC p10–p90) | 96.7% |
| Expected Sharpe (rf 4%) | -0.29 |
| Downside expectation (prob-weighted loss branches) | -35.4% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | -23.7% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 0.85 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Size/liquidity premium | +100bp |
| Required return | 8.8% |
| Expected alpha | -32.5% |
| Alpha per unit risk (EA/σ) | -0.34 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 47.2% (1σ) | 35.8% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 26.0% | 37.8% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $18.32.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 27 | AI | 64 | |
| Value | 15 | Cloud | 56 | |
| Quality | 26 | Semis | 66 | |
| Momentum | 10 | Consumer | 50 | |
| Low-Vol | 21 | Rates | 20 | |
| USD | 59 | |||
| Energy | 94 |
Market interaction: correlation vs SPY +0.30, vs QQQ +0.24 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Collar. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- bearish with rich premium — finance downside protection by selling an expensive call (collar)
- Direction bearish from the overlay conviction/rating (read-only input).
- IV/RV at the 79th percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 83rd percentile of its own month-end history (decile 9).
IV term structure (flat, slope +1.0pp): 32-DTE 47% · 116-DTE 49% · 389-DTE 48%
| Priced structure | Value |
|---|---|
| Legs | Long 21 P, Short 26 C |
| Expiry | 2027-03-19 |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Protective Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
research rating is SELL-tier — the model carries no long position.
| Parameter | Value |
|---|---|
| Initial position | 0.00% NAV |
| Maximum position | 0.00% NAV |
| Risk budget | 0.00% NAV |
| Annualized outcome σ (MC) | 96.7% |
| Indicative holding period | 6–18 months |
| Liquidity | medium, ~$190M ADV (adv usd 21 (split-adjusted 21d average, AM-046)) |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the SELL equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 47.3% (elevated regime) · expected move ±10.6% (2026-09-25) · put/call OI 0.67 · ATM Δ 0.53 / Θ -0.02 / ν 0.03. Direction: SHORT/HEDGE (implied return -28.1% to triangulated fair value $17.25).
Bear Put Spread (Bearish) — Long 24 P / Short 17.5 P · 2027-03-19 · net debit $2.4 · max profit $4.10 · breakeven $21.60 · RoR 171.0% · max loss $2.40 · priced from the listed chain (EOD marks)
Defined-risk downside expression: the debit caps the loss, with the position gaining as the stock falls toward the lower strike — a way to act on a bearish view without shorting stock. Illustrative — no outcome is implied or guaranteed.
Protective Put (if held) (Hedge) — Long 24 P · 2027-03-19 · premium $3.2 · floor 0.0% · max loss $3.20 · priced from the listed chain (EOD marks)
Insurance for an existing holding — a known premium buys a floor while leaving the upside intact. A way to hold through a binary event or volatility with defined downside.
Protective Collar (if held) (Hedge) — Long 21 P / Short 26 C · 2027-03-19 · net $0.73 · floor -12.0% · cap +8.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling. Elevated implied volatility currently enriches the premium collected.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = SELL because:
- Probability-weighted scenario value implies -24% vs spot
- Monte Carlo median implies -36% vs spot
- DCF fair value implies -70% vs spot
- Bear case (Structural — Nutrient Oversupply / Demand Reset) downside is -79% vs spot
- Net: the valuation anchor itself sits 28.1% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $13B | $0B | $1B | $1B | $0B | $0B |
| FY+2 | $13B | $0B | $1B | $1B | $0B | $0B |
| FY+3 | $13B | $0B | $1B | $1B | $0B | $0B |
| FY+4 | $13B | $0B | $1B | $1B | $0B | $0B |
| FY+5 | $13B | $0B | $2B | $1B | $0B | $0B |
| Terminal | — | — | — | — | $0B × 15.0x | $2B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 8% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.5% · Σ PV(FCF) $1B + PV(terminal) $2B = EV $3B; − net debt $0.9B → equity $2B ÷ diluted shares $0.31B = $7.30/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $7.12/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 0% vs WACC 9.5% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| CTVA | 3.1x | 22.8x | 5% | 24% |
| CF | 2.4x | 5.9x | 2% | 34% |
| AVY | 1.8x | 16.3x | 3% | 13% |
| BALL | 1.7x | 15.4x | 3% | 9% |
| Median | 2.1x | 15.8x | — | — |
Implied prices at the peer medians: EV/Rev → $80.65 (no P/E-implied price — no forward-EPS basis at the peer step).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| Scenario PWEV | $18.32 | 62% | $11.45 |
| Monte Carlo median | $15.46 | 37% | $5.80 |
| Triangulated | — | 100% | $17.25 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 9.5% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 15× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (27.0); Capex intensity ±15% (19.0); Revenue CAGR ±3pp (4.0); Terminal × ±15% (2.0); WACC ±1pp (1.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $12.4B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $12.7B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $0.3996 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.307B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $5.003B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 9.5% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 15× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 9.5%, terminal multiple 15×, FY+5 revenue $13B. Triangulation leans 62% on PWEV, 37% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-08-24 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.